Superior Planning, LLC’s Rigel Pharmaceuticals RIGL Stock Holding History

Superior Planning, LLC’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$144	Buy	+3	New	+$130	﹤0.01%	2060

Other funds holding RIGL

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

CM Management Gulf Breeze, Florida $149M AUM 35.54% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

O'Shaughnessy Asset Management Stamford, Connecticut $23.6B AUM 34.05% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Superior Planning, LLC's RIGL Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 3 shares worth $144. The stake represents ﹤0.01% of the portfolio and ranks #2060 among its holdings.

100 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

Superior Planning, LLC held 3 shares of Rigel Pharmaceuticals worth $144 as of Q3 2026.
Rigel Pharmaceuticals was a new Superior Planning, LLC position in Q3 2026.
Rigel Pharmaceuticals made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #2060 holding.
100 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.